Sign in
4

Changes in Ownership

Fulgent Genetics, Inc. Filed Acc 0001209191-20-045395

Chief Operating Officer sold 1,976 shares at $27.86 ($55,055)

  • Chief Operating Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Xie Jian · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-03 Grant or award : show line 1 in the form +200,000 603,712 D
2020-08-03 Sale : show line 2 in the form −1,976 $27.86 $55,055 601,736 D
Open-market sales · 1,976 sh · avg $27.86 · $55,055
Loading xslF345X03/doc4.xml…